[1]李金政,霍凤蕾,李志超,等.基于生物信息学及分子对接技术探究羌活胜湿汤治疗强直性脊柱炎的作用机制[J].西部中医药,2023,36(02):72-79.[doi:10.12174/j.issn.2096-9600.2023.02.16]
　LI Jinzheng,HUO Fenglei,LI Zhichao,et al.The Mechanism of Qianghuo Shengshi Tang in the Treatment of Ankylosing Spondylitis Based on Bioinformatics and Molecular Docking Technology[J].Western Journal of Traditional Chinese Medicine,2023,36(02):72-79.[doi:10.12174/j.issn.2096-9600.2023.02.16]
点击复制

基于生物信息学及分子对接技术探究羌活胜湿汤治疗强直性脊柱炎的作用机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年02期
页码:
72-79
栏目:
出版日期:
2023-02-15

文章信息/Info

Title:
The Mechanism of Qianghuo Shengshi Tang in the Treatment of Ankylosing Spondylitis Based on Bioinformatics and Molecular Docking Technology
作者:
李金政1, 霍凤蕾2, 李志超3, 邱红明4
1.山东中医药大学中医学院，山东 济南 250014
2.山东大学，山东 济南 250100
3.山东中医药大学，山东 济南 250355
4.山东中医药大学附属医院，山东 济南 250000
Author(s):
LI Jinzheng1, HUO Fenglei2, LI Zhichao3, QIU Hongming4
1.TCM school Shandong University of Traditional Chinese Medicine, Jinan 250014, China
2.Shandong University, Jinan 250100, China
3.Shandong University of Traditional Chinese Medicine, Jinan 250355, China
4.Affiliated Hospital to Shandong University of Traditional Chinese Medicine, Jinan 250000, China
关键词:
强直性脊柱炎; 羌活胜湿汤; 生物信息学; 差异基因; 分子对接; 机制
Keywords:
ankylosing spondylitis; bioinformatics; differentially expressed genes; molecular docking; mechanism
分类号:
R593.23
DOI:
10.12174/j.issn.2096-9600.2023.02.16
文献标志码:
A
摘要:
目的利用生物信息学及分子对接技术探究羌活胜湿汤治疗强直性脊柱炎的作用机制。 方法通过美国国家生物技术信息中心数据库（national center for biotechnology information，NCBI）、高通量基因表达数据库（gene expression omnibus，GEO）等数据库检索强直性脊柱炎相关芯片，利用R语言分析得到差异表达基因。借助人类基因数据库（GeneCards）、疾病基因数据库（DisGeNET）、孟德尔遗传综合数据库（online Mendelian inheritance in man，OMIM）、疾病数据库（MalaCards）、遗传药理学和药物基因组学数据库（pharmacogenetics and pharmacogenomics knowledge base，PharmGKB）等数据库对强直性脊柱炎已知靶基因进行检索与筛选，与差异表达基因去重取并集，对强直性脊柱炎的疾病靶基因进行预测。运用中药药理学平台（traditional chinese medicine systems pharmacology database and analysis platform，TCMSP）数据库对羌活胜湿汤七味中药的主要有效成分及作用靶基因进行筛选和挖掘，构建药物与疾病映射靶基因的蛋白质互作（protein-protein interaction，PPI）网络，通过基因注释（database for annotation，visualization and integrated discovery，David）数据库对药物-疾病关键靶基因进行生物通路及富集分析。最终将羌活胜湿汤中主要有效成分与关键靶基因进行分子对接。 结果羌活胜湿汤有效成分-靶基因网络图包含176个有效成分，相对应靶点137个；GEO数据库获得差异表达基因704个，通过疾病数据库检索与强直性脊柱炎发生发展相关的已知疾病靶标1323个，合并去重后共获得1950个已知疾病靶基因；最终获得映射靶基因46个，关键靶基因13个。羌活胜湿汤主要通过肿瘤坏死因子α（tumor necrosis factor-α，TNF-α）、白细胞介素6（interleukin-6，IL-6）、白细胞介素1β（interleukin-1β，IL-1β）、血管内皮生长因子A（vascular endothelial growth factor A，VEGFA）、氯霉素乙酰转移酶基因（chloramphnicol acetyltransferase，CAT）、雌激素受体1（estrogen receptor 1，ESR1）、环加氧酶2（prostaglandin-endoperoxide synthase 2，PTGS2）等作用于脂多糖介导的信号通路、一氧化氮生物合成过程的正调控、血管生成等生物过程及FoxO信号通路、炎症性肠病、各促炎因子相关信号通路等多个信号通路。分子对接结果显示：羌活胜湿汤中主要有效成分在与关键靶基因对接过程中均进入了活性位点，具有很强的结合能力。 结论应用生物信息学和分子对接技术方法可揭示羌活胜湿汤治疗强直性脊柱炎的潜在作用机制，具有较高的置信度和参考价值，为中药组方在治疗强直性脊柱炎方面提供了新的方向与思路。
Abstract:
ObjectiveTo explore the mechanism of Qianghuo Shengshi Tang in the treatment of ankylosing spondylitis (AS) based on bioinformatics and molecular docking technology. MethodsThe related chips of AS were retrieved from NCBI and GEO, differentially expressed genes (DGEs) were analyzed and obtained by using R language. The known target genes of AS were searched and screened via GeneCards, DisGeNET, OMIM, MalaCards and PharmGKB, and the target genes were predicted through taking the union set after removing the duplicate. The main active ingredients and the target genes of seven herbs contained in Qianghuo Shengshi Tang were screened and unearthed by using TCMSP, to construct PPI of medicine and disease mapping target genes, biological pathways and enrichment analysis of medicine and disease mapping target gene were conducted by using David. Consequently the main active components of Qianghuo Shengshi Tang were interlinked with key targets genes. ResultsNetwork chart of active ingredients-target genes of Qianghuo Shengshi Tang contained 176 active ingredients, 137 corresponding targets; 704 DGEs were obtained from GEO database, and 1323 known disease targets related to the incidence and development of AS were searched from disease database, and 1950 known disease target genes were gained after merging and removing the duplicate; finally, 46 mapping target genes and 13 key target genes were yielded. Qianghuo Shengshi Tang mainly acts on lipopolysaccharide-mediated signaling pathway, positive regulation of nitric oxide biosynthesis, biological processes such as angiogenesis, Fox0 signaling pathway, inflammatory bowel disease, and many signaling pathways including the ones related to proinflammatory factors through TNF-α, IL-6, IL-1β, VEGFA, CAT, ESR1 and PTGS2. The results of molecular docking displayed that the main active components of Qianghuo Shengshi Tang entered the active sites in the process of docking with key targets genes, showing the strongest combining capacity. ConclusionThe potential mechanism of Qianghuo Shengshi Tang in the treatment of AS could be revealed by applying bioinformatics and molecular docking technology, the method presents high confidence and reference value, and it could provide new direction and thinking for TCM formula in the treatment of AS.

相似文献/References:

[1]易竞阳.补肾强督祛风通络法治疗强直性脊柱炎临床疗效观察[J].西部中医药,2013,26(11):5.
　YI Jingyang.Clinical Observation on Treating Ankylosing Spondylitis with the Method of Kidney-nourishing Du-meridian-strengthening Wind-dispelling Collaterals-dredging[J].Western Journal of Traditional Chinese Medicine,2013,26(02):5.
[2]刘安国,严兴科△,阚丽丽,等.铺灸疗法为主治疗强直性脊柱炎的Meta分析*[J].西部中医药,2013,26(12):51.
　LIU Anguo,YAN Xingke,KAN Lili,et al.Meta Analysis of Primary Treatment for Ankylosing Spondylitis by Long Snake Moxibustion[J].Western Journal of Traditional Chinese Medicine,2013,26(02):51.
[3]刘渊,孙雪莲,周红海△.整脊经筋手法治疗强直性脊柱炎早中期患者临床研究*[J].西部中医药,2014,27(05):111.
　LIU Yuan,SUN Xuelian,ZHOU Honghai.Clinical Study on Treating the Patients with Ankylosing Spondylitis at Early and Medium Stages by Chiropractic and Meridian Manipulations[J].Western Journal of Traditional Chinese Medicine,2014,27(02):111.
[4]王爱华,指导：王海东.小针刀配合五劳七损方治疗强直性脊柱炎髋关节病变30例[J].西部中医药,2015,28(04):120.
[5]鄢卫平,李景周,强天明.针刀治疗强直性脊椎炎60例[J].西部中医药,2013,26(12):118.
　YAN Weiping,LI Jingzhou,QIANG Tianming.Treating 60 Cases of Ankylosing Spondylitis by Needle-knife[J].Western Journal of Traditional Chinese Medicine,2013,26(02):118.
[6]王智明,李伟青,田雪梅,等.针刀联合依那西普改善强直性脊柱炎脊柱功能障碍疗效观察[J].西部中医药,2016,29(01):119.
　WANG Zhiming,LI Weiqing,TIAN Xuemei,et al.Observation on Clinical Effects of Needle-knife Combined with Etanercept in Improving Spinal Dysfunction of Ankylosing Spondylitis[J].Western Journal of Traditional Chinese Medicine,2016,29(02):119.
[7]陈伯胜,王海东△,金芳梅,等.强直性脊柱炎与相关经络关系研究[J].西部中医药,2017,30(03):60.
　CHEN Bosheng,WANG Haidong,JIN Fangmei,et al.Study on the Relationship between Ankylosing Spondylitis and Related Meridians[J].Western Journal of Traditional Chinese Medicine,2017,30(02):60.
[8]李乐,王芳军△,刘连生.强直性脊柱炎MRI表现与中医证型相关性研究[J].西部中医药,2017,30(03):77.
　LI Le,WANG Fangjun,LIU Liansheng.Study of the Correlation between MRI Manifestations and TCM Syndrome Types in Patients with Ankylosing Spondylitis[J].Western Journal of Traditional Chinese Medicine,2017,30(02):77.
[9]连云,张建华,叶瑜娜.清痹愈风汤治疗湿热痹阻型强直性脊柱炎疗效观察[J].西部中医药,2018,31(07):79.
　LIAN Yun,ZHANG Jianhua,YE Yuna.Clinical Observation on QingBi YuFeng Decoction in Treating Ankylosing Spondylitis of Damp-heat Arthralgia Pattern[J].Western Journal of Traditional Chinese Medicine,2018,31(02):79.
[10]陈雯,马俊明,莫文△,等.施杞教授治疗强直性脊柱炎用药规律研究[J].西部中医药,2019,32(04):69.
　CHEN Wen,MA Junming,MO Wen,et al.Study on Professor Shi Qi′s Medication Rules of Treating Ankylosing Spondylitis[J].Western Journal of Traditional Chinese Medicine,2019,32(02):69.

备注/Memo

备注/Memo:
李金政（1995—），男，硕士学位。研究方向：骨关节与骨肿瘤疾病的临床诊治。国家自然科学基金（81473709）；曹贻训全国名老中医传承工作室建设项目（国中医药人教函［2018］134号）。
更新日期/Last Update: 2023-02-15